Immunotherapy Combination Approved for First-Line Kidney Cancer Treatment April 16, 2018October 31, 2024 Arthur N. Brodsky, PhD
Phase 3 Trial Shows Nivolumab Improves Survival in Advanced Kidney Cancer July 20, 2015December 14, 2022 Matthew Tontonoz